/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mariateresa Giuliano

University of Campania "Luigi Vanvitelli"(IT)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

64

Papers

2.3K

Citations

24

h-index

31

i10-index

Mariateresa Giuliano is an academic researcher from University of Campania "Luigi Vanvitelli". The author has contributed to research in topics: Advanced Breast Cancer Therapies & Occupational and environmental lung diseases & Cancer Treatment and Pharmacology. The author has an h-index of 24, co-authored 55 publications.

ORCID: 0000-0002-7338-9200

Research Topics

Advanced Breast Cancer Therapies Occupational and environmental lung diseases Cancer Treatment and Pharmacology Immune Response and Inflammation Enzyme Production and Characterization

Papers by this author

works

Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity

2011 · BMC Medicine · 444 citations

https://doi.org/10.1186/1741-7015-9-23

Anna Sapone Karen M. Lammers Vincenzo Casolaro Marcella Cammarota

Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study

2025 · Annals of Oncology · 26 citations

https://doi.org/10.1016/j.annonc.2025.03.023

L. Provenzano M.V. Dieci G. Curigliano Mariateresa Giuliano

357P Bridging the gap between real-world studies (RWSs) and randomized controlled trials (RCTs) of 1st-line palbociclib+aromatase inhibitors (P+AI) in hormone receptor-positive (HR+)/HER2-negative(-) metastatic breast cancer (mBC)

2024 · Annals of Oncology · 0 citations

https://doi.org/10.1016/j.annonc.2024.08.305

S. Nucera F. Schettini Fabiola Giudici Carla Strina

Exploring Isolated Tumor Cells Entity In Endometrial Cancer

2025 · International Journal of Gynecological Cancer · 0 citations

https://doi.org/10.1016/j.ijgc.2024.100252

Vito Andrea Capozzi Emanuele Perrone Elisa Scarpelli Vincenzo Tarantino

309P Prognostic and predictive value of lobular tumor histology in advanced HR+/HER2- breast cancer treated with ET plus CDK4/6i: A sub-analysis of the PALMARES-2 study

2025 · ESMO Open · 0 citations

https://doi.org/10.1016/j.esmoop.2025.104881

C. Vernieri M.V. Dieci G. Curigliano Mariateresa Giuliano

498P Impact of estrogen receptor expression on real-world effectiveness of first-line ET+CDK4/6i in patients with HR+/HER2- advanced BC

2025 · Annals of Oncology · 0 citations

https://doi.org/10.1016/j.annonc.2025.08.921

C. Vernieri M.V. Dieci R. Caputo Paolo Vigneri

Research topics

topics

Advanced Breast Cancer Therapies

Occupational and environmental lung diseases

Cancer Treatment and Pharmacology

Immune Response and Inflammation

Enzyme Production and Characterization

Chat about Author

Papers

Chat

Click to start Chat